Decreasing incidence of renal replacement therapy over time at the critical 50-59-year age range suggests a role for nephroprotective therapy in ADPKD Reply

Edwin M. Spithoven*, Ron T. Gansevoort

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)194-195
Number of pages4
JournalKidney International
Volume88
Issue number1
DOIs
Publication statusPublished - Jul-2015

Keywords

  • POLYCYSTIC KIDNEY-DISEASE

Cite this